<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome (AS)</z:e> is a neurogenetic syndrome, has a prevalence of 1:10,000 to 1:40,000 </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with AS have genetic alterations in <z:mp ids='MP_0003122'>maternal imprinting</z:mp> gene UB3A (15q11-q13) and molecular evaluations confirm the diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>Our aim is to report a new case with AS and subclinical <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> (SCH) without <z:hpo ids='HP_0000853'>goiter</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Thyroid dysfunction has not been described as part of alterations in AS; the exact pathogenic mechanisms of SCH in patients with AS remains incompletely unknown </plain></SENT>
</text></document>